Navigation Links
Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
Date:8/14/2012

ic alliances with AstraZeneca, GlaxoSmithKline and Sanofi.

For more information, please visit http://www.regulusrx.com. Regulus is also on YouTube at http://www.youtube.com/user/RegulusRx#p/f and on Twitter at www.twitter.com/regulusrx.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.

Forward-Looking Statements

This press release includes forward-looking statements regarding the future therapeutic and commercial potential of Isis', Alnylam's and Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus, including statements regarding expectations around the newly formed relationship between Regulus and AstraZeneca.  Any statement describing Isis', Alnylam's or Regulus' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Such parties' forward-looking statements also involve assumptions that, if they never materialize or prove
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nile Therapeutics Reports 2012 Second Quarter Financial Results
2. Zenobia Therapeutics Announce A Partnership With The Alzheimers Drug Discovery Foundation
3. Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
4. Echo Therapeutics Announces Second Quarter 2012 Financial Results
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
6. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur Life Sciences
7. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
8. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
9. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
10. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
11. Silence Therapeutics - Admission of Shares and Board Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...  VA North Texas Health Care System announces ... a technology-based, scientifically advanced weight loss therapy.  ... the Maestro® Rechargeable System that intermittently blocks intra-abdominal ... food intake and processing between the brain and ... to meet the needs of a patient,s changing ...
(Date:6/3/2015)... , June 3, 2015 aTyr Pharma, Inc. (NASDAQ: ... and development of Physiocrine-based therapeutics to address rare diseases, today ... William Blair Growth Stock Conference to be held at the ... June 9-11, 2015. John Mendlein , aTyr,s ... on the Company at 9:20 a.m. CT on Wednesday, June ...
(Date:6/3/2015)... 2015  Armetheon, Inc., a specialty pharmaceutical company ... today announced that Sanjay Kakkar , MD, ... effective immediately. Dr. Kakkar brings more than 20 ... a successful track record in advancing novel technologies ... that includes the development of novel drugs and ...
Breaking Medicine Technology:VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Patient Record Sharing , and Secure ... Among Physicians , DAYTON, Ohio, Oct. 29 ... (HSI) announce an effort to create virtual teams that connect primary ... care of patients, improving the quality and safety of care while ...
... IRVINE, Calif., Oct. 29 PRO-DEX, INC. (Nasdaq: PDEX ... quarter ending September 30, 2009. In addition, Pro-Dex announced ... renewed, a new marketing director has been hired, a product ... shipments have been made of a newly developed product. , ...
Cached Medicine Technology:Family Medicine Education Consortium, Inc. Endorses PatientCarenet.Org 2Family Medicine Education Consortium, Inc. Endorses PatientCarenet.Org 3Family Medicine Education Consortium, Inc. Endorses PatientCarenet.Org 4PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 2PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 3PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 4PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 5PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 6PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 7PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 8PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 9PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 10
(Date:6/3/2015)... (PRWEB) June 03, 2015 Acne is the ... can be particularly stubborn to eliminate and hard to prevent. ... common in teens and young adults, in the years when ... sebum, or oil,” says Jayme Bashian, director and lead medical ... pimples, blackheads and cysts of acne are caused by oil ...
(Date:6/3/2015)... 2015 First Choice Emergency Room ... in the United States, announced that it is opening ... June. , “I am pleased to announce that ... new facility in the San Antonio area,” said Dr. ... Emergency Room. , First Choice Emergency Room is ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Come on ... Relay , a 200-mile overnight relay beginning in Madison, ... Illinois on Saturday, June 13th. , For the 4th ... the Brainstormers will run to raise money for the ... of different members of the Neurosurgery staff from The ...
(Date:6/2/2015)... 03, 2015 BALTIMORE, Md. – ... a book about wellness after being diagnosed with lupus. ... that through lifestyle changes which enhance health, lupus and ... “ A Wellspring for Wellness ,” she offers a ... , This book provides an overview of some autoimmune ...
(Date:6/2/2015)... Aidan Booth And Steve Clayton's ... yesterday, and has since received rave reviews from ... Tiffany Hendricks has weighed in with her opinion ... on her website HonestyFirstReviews.com. , "These days the ... looking to hone their business skills has gotten ...
Breaking Medicine News(10 mins):Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2
... Medical Center has just enrolled the first U.S. patient in ... certain kinds of melanoma, a deadly skin cancer that in ... than blocking or killing all rapidly dividing cells, whether malignant ... new class of agents that have been designed to sabotage ...
... Nov. 30 (HealthDay News) -- Patients have better outcomes ... a new review. The researchers analyzed 298 studies ... led to improved outcomes in a number of important ... and lower cholesterol. Pharmacist participation in patient care ...
... 30 (HealthDay News) -- Early assessment of rheumatoid arthritis ... the likelihood of disease remission without having to take ... Although DMARDs are considered effective in treating rheumatoid ... been linked to uncommon but serious side effects. ...
... their employer, or through an employed family member,s dependent coverage. ... to a new policy brief from the UCLA Center for ... California Health Interview Survey (CHIS), the brief,s authors found that ... with at least one employed family member or 5.7 ...
... of more than 2 million mammogram screenings performed on nearly ... time show a direct link between reduced hormone therapy and ... invasive breast cancer. The researchers saw such a striking decrease, ... promote breast tumor growth. The declines occurred in ...
... system for Wilson,s disease (WD) provides good diagnostic accuracy ... in children with mild liver disease. In asymptomatic children, ... suggestive of WD, however the penicillamine challenge test (PCT) ... subset. Results of the study appear in the December ...
Cached Medicine News:Health News:International clinical trial tests targeted drug for melanoma 2Health News:Better Outcomes Seen With Early Rheumatoid Arthritis Diagnosis 2Health News:5.7 million Californians lack access to job-based coverage 2Health News:Drop in breast cancer rates directly tied to reduced hormone therapy 2Health News:Drop in breast cancer rates directly tied to reduced hormone therapy 3Health News:Scoring system is 93 percent accurate for diagnosing Wilson's disease in pediatric patients 2
... The IntraLase FS laser introduces new high ... Surgeons now have the opportunity to offer ... to a microkeratome for creating the corneal ... FS laser and proprietary IntraLASIK software, surgeons ...
... simple, effective screening test which is used to ... levels which are often a warning sign of ... which requires a single drop of blood obtained ... shown in clinical trials to be 94 to ...
The Lifestream Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program. At a later date, you can purchase the other components...
... using patented, innovative technology, measures a complete ... only 5 minutes from a simple fingerstick. ... get immediate liver function results. The scope ... only advantage to healthcare providers. The physician, ...
Medicine Products: